redipred prednisolone 25mg/5ml (as sodium phosphate) oral liquid bottle
aspen pharmacare australia pty ltd - prednisolone sodium phosphate, quantity: 6.72 mg/ml (equivalent: prednisolone, qty 5 mg/ml) - oral liquid, solution - excipient ingredients: disodium edetate; dibasic sodium phosphate; propyl hydroxybenzoate; sorbitol solution (70 per cent) (non-crystallising); methyl hydroxybenzoate; purified water; monobasic sodium phosphate; flavour - wherever corticosteroid therapy is indicated.
oral saline laxative- dibasic sodium phosphate, monobasic sodium phosphate liquid
walgreen co - sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, monobasic (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr) - saline laxative
osmoprep- sodium phosphate, monobasic, monohydrate, sodium phosphate, dibasic anhydrous tablet
salix pharmaceuticals, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, monobasic, monohydrate 1.102 g - osmoprep® is indicated for cleansing of the colon as a preparation for colonoscopy in adults. osmoprep is contraindicated in the following conditions: risk summary there are no available data on sodium phosphate use in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with sodium phosphate. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary there are no data available to assess the presence of sodium phosphate in human milk, the effects of the drug on the breastfed infant, or the effects of the drug on milk production. the lack of clinical data during lactation precludes a clear determinat
sodium phosphate 16% / 6% rectal solution
lab. chimico farmaceutico a sella s.r.l via vicenza 67, schio, italy - sodium phosphate, dibasic dodecahydrate, monobasic dihydrate - rectal solution - sodium phosphate dibasic dodecahydrate 8 % (w/v) sodium phosphate monobasic dihydrate 18.1 % (w/v) - drugs for constipation
sodium phosphate 10 tablet
biocentre - sodium phosphate dibasic - tablet - 6x - sodium phosphate dibasic 6x - homeopathic products
sodium phosphate liquid (s#132)
total health centre - sodium phosphate dibasic - liquid - 1x - sodium phosphate dibasic 1x - homeopathic products
sodium phosphates- sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous injection, solution
fresenius kabi usa, llc - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, dibasic, anhydrous (unii: 22ado53m6f) (sodium cation - unii:lyr4m0nh37) - sodium phosphates injection, usp, 3 mm p/ml is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific parenteral fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. the concomitant amount of sodium (na+ 4 meq/ml) must be calculated into total electrolyte dose of such prepared solutions. sodium phosphate is contraindicated in diseases where high phosphorus or low calcium levels may be encountered, and in patients with hypernatremia.
saline laxative- sodium phosphate enema
walgreen company - sodium phosphate, dibasic, unspecified form (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic 7 g in 118 ml - - relieves occasional constipation - this product generally produces bowel movement in 1 to 5 minutes
pure and gentle laxative- sodium phosphate enema
medline industries, lp - sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr), sodium phosphate, monobasic (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr) - sodium phosphate, dibasic 7 g in 118 ml - saline laxative - relieves occasional constipation - this product generally produces bowel movement in 1 to 5 minutes
ready-to-use- sodium phosphate enema
rugby laboratories, inc. - sodium phosphate, dibasic, unspecified form (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, monobasic, unspecified form (unii: 3980jih2sw) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium phosphate, dibasic 7 g in 118 ml - - relieves occasional constipation - this product generally produces bowel movement in 1 to 5 minutes